Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Helsby

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Environmental Toxicology and Pharmacology|July 26, 2011
Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?M D Tingle, N A Helsby
British Journal of Clinical Pharmacology|April 1, 1995
The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanidesJ D Wright, N A Helsby, S A Ward
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 14, 1998
Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equolN A Helsby, J K Chipman, A Gescher, et al.
British Journal of Clinical Pharmacology|June 1, 1993
The multiple dose pharmacokinetics of proguanilN A Helsby, G Edwards, A M Breckenridge, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2010
Do 5-fluorouracil therapies alter CYP2C19 metaboliser status?N A Helsby, W Y Lo, P Thompson, et al.
Parasitology Today (Personal Ed.)|January 1, 1991
Inter-individual variation in the metabolic activation of the antimalarial biguanidesN A Helsby, W M Watkins, E Mberu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1997
The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cellsN A Helsby, J Williams, D Kerr, et al.
British Journal of Clinical Pharmacology|August 1, 1990
In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzymeN A Helsby, S A Ward, R E Howells, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2014
CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activityK E Burns, M A Goldthorpe, F Porteus, et al.
Mutation Research|October 18, 2000
Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymesN A Helsby, S Zhu, A E Pearson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Environmental Toxicology and Pharmacology|July 26, 2011
Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?M D Tingle, N A Helsby
British Journal of Clinical Pharmacology|April 1, 1995
The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanidesJ D Wright, N A Helsby, S A Ward
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 14, 1998
Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equolN A Helsby, J K Chipman, A Gescher, et al.
British Journal of Clinical Pharmacology|June 1, 1993
The multiple dose pharmacokinetics of proguanilN A Helsby, G Edwards, A M Breckenridge, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2010
Do 5-fluorouracil therapies alter CYP2C19 metaboliser status?N A Helsby, W Y Lo, P Thompson, et al.
Parasitology Today (Personal Ed.)|January 1, 1991
Inter-individual variation in the metabolic activation of the antimalarial biguanidesN A Helsby, W M Watkins, E Mberu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1997
The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cellsN A Helsby, J Williams, D Kerr, et al.
British Journal of Clinical Pharmacology|August 1, 1990
In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzymeN A Helsby, S A Ward, R E Howells, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2014
CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activityK E Burns, M A Goldthorpe, F Porteus, et al.
Mutation Research|October 18, 2000
Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymesN A Helsby, S Zhu, A E Pearson, et al.
Pageof 2